Sandoz Admits To Widescale Infringement In Resolving US Rinvoq Patent Tussle
Hetero, Aurobindo, Sun Pharma Remain In Litigation Over $6bn JAK Inhibitor
Sandoz has reached an agreement with AbbVie to dismiss without prejudice patent-infringement litigation involving more than 20 patents shielding the originator’s blockbuster JAK inhibitor Rinvoq.
